European drug regulator allows Novo to include reduction of kidney disease in Ozempic labelReuters • 12/12/24
Novo Nordisk A/S: European regulatory authority adopts positive opinion for an update of the Ozempic® label to reflect risk reduction of kidney disease-related eventsGlobeNewsWire • 12/12/24
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closingCNBC • 12/11/24
Eikonizo Therapeutics Announces Investment by Novo Nordisk; Advancing Lead Candidate EKZ-102 Toward Clinical DevelopmentBusiness Wire • 12/10/24
The Zacks Analyst Blog Berkshire Hathaway, Exxon Mobil, Novo Nordisk and Universal Health Realty Income TrustZacks Investment Research • 12/09/24
The European Commission approves the acquisition of Catalent by Novo Holdings and the related acquisition by Novo Nordisk of three manufacturing sites from Novo HoldingsGlobeNewsWire • 12/06/24
Novavax to Sell Czech Manufacturing Plant to Novo Nordisk for $200MZacks Investment Research • 12/05/24
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trialCNBC • 12/04/24
Want To Bet On Ozempic, Wegovy Success? Defiance Introduces Leveraged ETF To Capture Novo Nordisk MomentumBenzinga • 12/03/24
Novo Nordisk to present new data from sickle cell disease and haemophilia trials at the 66th American Society of Hematology (ASH) annual meetingGlobeNewsWire • 12/03/24
Novo Nordisk and AstraZeneca top of the 2025 drug picks for US investment bank - read whyProactive Investors • 12/03/24
Defiance Launches NVOX, the First 2X Leveraged Single-Stock ETF on Novo NordiskGlobeNewsWire • 12/03/24
Exclusive: Novo Nordisk India execs urge early Wegovy launch as weight-loss rival loomsReuters • 12/03/24